Genomic Vision 

0
0
+€0,00+0% 00:00 Hoje

Estatísticas

Máxima do dia
-
Mínima do dia
-
Máxima 52S
-
Mín 52S
-
Volume
-
Vol. médio
-
Cap. de mercado
0
P/L
-
Rendimento de dividendos
-
Dividendo
-

Concorrentes

Esta lista é uma análise baseada em eventos recentes do mercado. Não é uma recomendação de investimento.

Sobre

Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides CombHeliX FSHD probes for the diagnosis of facioscapulohumeral dystrophy; FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur; and development agreement with Integrated Technologies Ltd for the design and development of a high-throughput scanning instrument for molecular combing assays. The company was founded in 2004 and is headquartered in Bagneux, France.
Mostrar mais
CEO
Mr. Aaron Bensimon
Funcionários
27
País
França
ISIN
FR0011799907
WKN
000A110TM

Listagens

0 comentários

Compartilhe suas ideias

Perguntas frequentes

Qual é o símbolo da ação da Genomic Vision?▼
Dependendo da bolsa, o símbolo da ação pode variar. Por exemplo, na bolsa Boerse Muenchen, as ações da Genomic Vision são negociadas sob o símbolo G09.MU.
Quantos funcionários a Genomic Vision tem?▼
Em 1 de novembro de 2026, a empresa tem 27 funcionários.
Em que setor está localizada a Genomic Vision?▼
Genomic Vision atua no setor de Saúde e Bem-estar.
Quando a Genomic Vision concluiu o desdobro de ações?▼
Genomic Vision não teve nenhum desdobro recente.
Onde fica a sede da Genomic Vision?▼
A sede da Genomic Vision fica em Bagneux, França.